Company Filing History:
1 out of 832,718 Years Active: 1994
Title: Evgeny V Larionov: Innovator in Biocompatible Materials
Introduction
Evgeny V Larionov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biocompatible materials, showcasing his expertise through innovative patents. His work focuses on developing materials that can be used in various medical applications, emphasizing safety and compatibility with biological systems.
Latest Patents
Larionov holds a patent for a biocompatible polymer material and a process for producing the same. This biocompatible material is the result of graft-copolymerization of a water-soluble vinyl and/or an acrylate monomer with a sorption complex of polysilicic acid and collagen. The material has been refined to remove pigments, glycoproteins, and proteoglycans, ensuring its suitability for medical use. The patent details methods of making the material and the products produced from it, highlighting its composition, which includes up to 25 mass percent of polysilicic acid, up to 12 mass percent of protein, and a minimal amount of hydrofluoric acid anions.
Career Highlights
Throughout his career, Larionov has demonstrated a commitment to advancing the field of biocompatible materials. His innovative approach to material science has led to the development of products that can significantly impact medical treatments and patient care. His patent reflects his dedication to creating safer and more effective materials for use in healthcare.
Collaborations
Larionov has collaborated with notable colleagues in his field, including Svyatoslav N Fedorov and Sergei Nikolayevich Bagrov. These collaborations have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Evgeny V Larionov is a prominent figure in the development of biocompatible materials, with a patent that underscores his innovative contributions to the field. His work continues to pave the way for advancements in medical applications, enhancing the safety and effectiveness of treatments.